한글목차

기질 혈관 분획 동향과 예측

세계 기질 혈관 분획 시장은 2024년부터 2030년까지 5.1%의 CAGR로 2030년까지 약 1억 2,300만 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 골격 및 근육 질환의 유병률 증가, 줄기세포 치료에 대한 인식과 지식의 증가, 재생 의학으로의 움직임 증가, 많은 전임상 및 임상 연구 시도 등입니다. 세계 기질 혈관 분획 시장의 미래는 병원, 전문 클리닉, 줄기세포 은행/연구소 시장의 기회로 인해 유망합니다.

기질 혈관 분획 시장 인사이트

Lucintel은 예측 기간 동안 연부 조직에 대한 적용이 가장 큰 부문이 될 것으로 예상하고 있습니다.

아시아태평양은 지방의 민간 병원 증가 등 민간 의료 시설의 지속적인 확대로 인해 예측 기간 동안 가장 큰 지역으로 남을 것입니다. 기질 혈관 분획은 첨단 기술 개발과 수요 증가에 힘입어 지속적인 연구 개발 이니셔티브의 수혜를 받을 것입니다.

이 보고서는 다음과 같은 11가지 주요 질문에 대한 답을 제시합니다:

• Q.1. 시장 부문 중 가장 유망하고 성장성이 높은 기회는 무엇인가?
• Q.2. 어떤 분야가 더 빠른 속도로 성장할 것이며, 그 이유는 무엇인가?
• Q.3. 향후 성장이 가속화될 것으로 예상되는 지역과 그 이유는?
• Q.4. 시장 역학에 영향을 미치는 주요 요인은 무엇인가? 시장의 주요 과제와 비지니스 리스크는 무엇인가?
• Q.5. 이 시장에서의 비지니스 리스크와 경쟁 위협은 무엇인가?
• Q.6. 이 시장의 새로운 트렌드와 그 이유는?
• Q.7. 시장에서의 고객 수요 변화에는 어떤 것들이 있는가?
• Q.8. 이 시장의 새로운 발전과 그 발전을 주도하고 있는 기업은?
• Q.9. 이 시장의 주요 기업은? 주요 기업들은 사업 성장을 위해 어떤 전략적 노력을 기울이고 있는가?
• Q.10. 이 시장의 경쟁 제품에는 어떤 것들이 있으며, 소재 및 제품 대체에 따른 시장 점유율 하락의 위협은 어느 정도인가?
• Q.11. 지난 5년간 어떤 M&A가 이루어졌고, 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 기질 혈관 분획 시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 기질 혈관 분획 시장 동향(2018-2023)과 예측(2024-2030)
• 제품별 세계의 기질 혈관 분획 시장
  • SVF 흡인 제품
  • SVF 이송 제품
  • SVF 격리 제품
• 용도별 세계 기질 혈관 분획 시장
  • 미용 용도
  • 정형외과 용도
  • 연조직 용도
  • 기타
• 최종 용도별 세계 기질 혈관 분획 시장
  • 병원
  • 전문 클리닉
  • 줄기세포 은행/연구소
  • 기타

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 세계의 기질 혈관 분획 시장
• 북미의 기질 혈관 분획 시장
• 유럽의 기질 혈관 분획 시장
• 아시아태평양의 기질 혈관 분획 시장
• 기타 지역의 기질 혈관 분획 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 제품별 세계의 기질 혈관 분획 시장 성장 기회
  • 용도별 세계 기질 혈관 분획 시장 성장 기회
  • 최종 용도별 세계 기질 혈관 분획 시장 성장 기회
  • 지역별 세계의 기질 혈관 분획 시장 성장 기회
• 세계의 기질 혈관 분획 시장의 새로운 동향
• 전략적 분석
  • 신제품의 개발
  • 세계의 기질 혈관 분획 시장 능력 확대
  • 세계의 기질 혈관 분획 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 유력 기업의 기업 개요

• Cytori Therapeutics
• IntelliCell BioSciences
• Cellular Biomedicines Group
• Lifecell
• Tissue Genesis
• InGeneron
• Human med
• Hairline International
• Genesis Biosystems
• Kyocera

영문목차

Stromal Vascular Fraction Trends and Forecast

The future of the global stromal vascular fraction market looks promising with opportunities in the hospital, specialty clinic, and stem cell banks/laboratory markets. The global stromal vascular fraction market is expected to reach an estimated $123 million by 2030 with a CAGR of 5.1% from 2024 to 2030. The major drivers for this market are increasing prevalence of skeletal and muscular ailments, growing recognition and knowledge regarding stem cell therapy, increasing movement towards regenerative medicine, and numerous pre-clinical and clinical research endeavors.

A more than 150-page report is developed to help in your business decisions.

Stromal Vascular Fraction by Segment

The study includes a forecast for the global stromal vascular fraction by product, application, end use, and region.

Stromal Vascular Fraction Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• SVF Aspiration Products
• SVF Transfer Products
• SVF Isolation Products

Stromal Vascular Fraction Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Cosmetic Applications
• Orthopedic Applications
• Soft Tissue Applications
• Others

Stromal Vascular Fraction Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Specialty Clinics
• Stem Cell Banks/Laboratories
• Others

Stromal Vascular Fraction Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Stromal Vascular Fraction Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies stromal vascular fraction companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the stromal vascular fraction companies profiled in this report include-

• Cytori Therapeutics
• Intellicell Biosciences
• Cellular Biomedicines Group
• Lifecell
• Tissue Genesis
• Ingeneron
• Human Med
• Hairline International
• Genesis Biosystems
• Kyocera

Stromal Vascular Fraction Market Insights

Lucintel forecasts that soft tissue application will remain the largest segment over the forecast period.

APAC will remain the largest region over the forecast period due to ongoing expansion of private healthcare facilities, including a rising number of private hospitals in rural regions, stromal vascular fraction stands to benefit from ongoing research and development initiatives, spurred by the growing development and demand for cutting-edge technologies.

Features of the Global Stromal Vascular Fraction Market

Market Size Estimates: Stromal vascular fraction market size estimation in terms of value ($M).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Stromal vascular fraction market size by product, application, end use, and region in terms of value ($M).

Regional Analysis: Stromal vascular fraction market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, application, end use, and regions for the stromal vascular fraction market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the stromal vascular fraction market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the stromal vascular fraction market size?

Answer: The global stromal vascular fraction market is expected to reach an estimated $123 million by 2030.

Q.2 What is the growth forecast for stromal vascular fraction market?

Answer: The global stromal vascular fraction market is expected to grow with a CAGR of 5.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the stromal vascular fraction market?

Answer: The major drivers for this market are increasing prevalence of skeletal and muscular ailments, growing recognition and knowledge regarding stem cell therapy, increasing movement towards regenerative medicine, and numerous pre-clinical and clinical research endeavors.

Q4. What are the major segments for stromal vascular fraction market?

Answer: The future of the global stromal vascular fraction market looks promising with opportunities in the hospital, specialty clinic, and stem cell banks/laboratory markets.

Q5. Who are the key stromal vascular fraction market companies?

Answer: Some of the key stromal vascular fraction companies are as follows:

• Cytori Therapeutics
• Intellicell Biosciences
• Cellular Biomedicines Group
• Lifecell
• Tissue Genesis
• Ingeneron
• Human Med
• Hairline International
• Genesis Biosystems
• Kyocera

Q6. Which stromal vascular fraction market segment will be the largest in future?

Answer: Lucintel forecasts that soft tissue application will remain the largest segment over the forecast period.

Q7. In stromal vascular fraction market, which region is expected to be the largest in next 5 years?

Answer: APAC will remain the largest region over the forecast period due to ongoing expansion of private healthcare facilities, including a rising number of private hospitals in rural regions, stromal vascular fraction stands to benefit from ongoing research and development initiatives, spurred by the growing development and demand for cutting-edge technologies.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the stromal vascular fraction market by product (SVF aspiration products, SVF transfer products, and SVF isolation products), application (cosmetic applications, orthopedic applications, soft tissue applications, and others), end use (hospitals, specialty clinics, stem cell banks/laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Stromal Vascular Fraction Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Stromal Vascular Fraction Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Stromal Vascular Fraction Market by Product
  • 3.3.1: SVF Aspiration Products
  • 3.3.2: SVF Transfer Products
  • 3.3.3: SVF Isolation Products
• 3.4: Global Stromal Vascular Fraction Market by Application
  • 3.4.1: Cosmetic Applications
  • 3.4.2: Orthopedic Applications
  • 3.4.3: Soft Tissue Applications
  • 3.4.4: Others
• 3.5: Global Stromal Vascular Fraction Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Specialty Clinics
  • 3.5.3: Stem Cell Banks/Laboratories
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Stromal Vascular Fraction Market by Region
• 4.2: North American Stromal Vascular Fraction Market
  • 4.2.1: North American Stromal Vascular Fraction Market by Application: Cosmetic Applications, Orthopedic Applications, Soft Tissue Applications, and Others
  • 4.2.2: North American Stromal Vascular Fraction Market by End Use: Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories, and Others
• 4.3: European Stromal Vascular Fraction Market
  • 4.3.1: European Stromal Vascular Fraction Market by Application: Cosmetic Applications, Orthopedic Applications, Soft Tissue Applications, and Others
  • 4.3.2: European Stromal Vascular Fraction Market by End Use: Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories, and Others
• 4.4: APAC Stromal Vascular Fraction Market
  • 4.4.1: APAC Stromal Vascular Fraction Market by Application: Cosmetic Applications, Orthopedic Applications, Soft Tissue Applications, and Others
  • 4.4.2: APAC Stromal Vascular Fraction Market by End Use: Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories, and Others
• 4.5: ROW Stromal Vascular Fraction Market
  • 4.5.1: ROW Stromal Vascular Fraction Market by Application: Cosmetic Applications, Orthopedic Applications, Soft Tissue Applications, and Others
  • 4.5.2: ROW Stromal Vascular Fraction Market by End Use: Hospitals, Specialty Clinics, Stem Cell Banks/Laboratories, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Stromal Vascular Fraction Market by Product
  • 6.1.2: Growth Opportunities for the Global Stromal Vascular Fraction Market by Application
  • 6.1.3: Growth Opportunities for the Global Stromal Vascular Fraction Market by End Use
  • 6.1.4: Growth Opportunities for the Global Stromal Vascular Fraction Market by Region
• 6.2: Emerging Trends in the Global Stromal Vascular Fraction Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Stromal Vascular Fraction Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Stromal Vascular Fraction Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Cytori Therapeutics
• 7.2: IntelliCell BioSciences
• 7.3: Cellular Biomedicines Group
• 7.4: Lifecell
• 7.5: Tissue Genesis
• 7.6: InGeneron
• 7.7: Human med
• 7.8: Hairline International
• 7.9: Genesis Biosystems
• 7.10: Kyocera